.j ujCkj uj icuovuuj gent mciupy, i c nun. 
References 
Anderson, W.F. (1985). Human gene therapy: scientific and ethical considerations. J Med 
Phil 10:275-291,1985. 
Anderson, R. A., Kato, S., and Camerini-Otero, R. D. (1984). A pattern of partially 
homologous recombination in mouse L cells. Proc. Natl. Acad Sci. USA 81:206- 
210 . 
Bandyopadhyay, P. K., Watanabe, S., and Temin, H. M. (1984). Recombination of trans- 
fected DNAs in vertebrate cells in culture. Proc Natl Acad Sci USA 81:3476- 
3480. 
Barnes, F. (1986). Please go away. The New Republic 194:7-8. 
Bishop, J.M. and Varmus, H. (1982). Functions and origins of retroviral transforming 
genes. In RNA Tumor Viruses. The Molecular Biology of Tumor Viruses, second 
edition, R. Weiss, N. Teich, H.E. Varmus and J. Coffin (Eds.), Cold Spring Har- 
bor Laboratory', Cold Spring Harbor, N.Y., pp. 999-1108. 
Blohme, I. (1985). Malignant disease in renal transplant patients. Transplantation 39:23- 
25. 
Coffin, J.M. (1986). Cell 
Coffin, J. M., Tsichlis, P. N„ Barker, C. S., Voynow, S., and Robinson, H. L. (1980). 
Variation in avian retrovirus genomes. Ann NY Acad Sci 354:410-425. 
Dougherty, J. and Temin, H. M. (1986a). High mutation rate of a spleen necrosis virus- 
based retrovirus vector. Mol Cell Biol. 
Dougherty, J. and Temin, H. M. (1986b). In preparation. 
Fischoff (1981). Acceptable Risk. Cambridge University Press, NY. 
Gelinas, C and Temin, H.M. (1986). Nondefective spleen necrosis virus vectors define 
the upper size limit for packaging of reticuloendotheliosis viruses. 
Recombinant DNA Research, Volume 12 
[391] 
